InsidersTradesSigma
Follow the CAN share price and the full management transaction log of the company, a listed equity based in Australia. Shares trade on AU AU, under the oversight of ASX. Operating in the Health Care sector, CAN has published 2 insider filings. Market capitalisation: €6.6m. The latest transaction was filed on 29 June 2026 (Cease Substantial Holding). Among the most active insiders: 129 188 450 REGAL PARTNERS LIMITED. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
CAN is a company operating in the healthcare and pharmaceutical sector. It is listed on the XASX market.